Company Filing History:
Years Active: 2004-2012
Title: Michael J Treuheit: Innovator in Therapeutic Formulations
Introduction
Michael J Treuheit is a notable inventor based in Newbury Park, California. He has made significant contributions to the field of therapeutic formulations, holding a total of three patents. His work focuses on innovative solutions that enhance the stability and efficacy of pharmacological compounds.
Latest Patents
One of Treuheit's latest patents is for therapeutic formulations of keratinocyte growth factor. This invention provides long-term stable formulations of lyophilized keratinocyte growth factor and outlines methods for creating a lyophilized composition that includes this important growth factor. Another significant patent is for a process aimed at correcting disulfide misfolds in Fc molecules. This process involves preparing a pharmacologically active compound with an Fc domain, treating the fusion molecule with a copper (II) halide, and isolating the treated fusion molecule. The preferred copper (II) halide used in this process is CuCl, with specific concentrations recommended for different types of fusion molecules.
Career Highlights
Throughout his career, Treuheit has worked with prominent companies in the biotechnology sector, including Amgen Inc. and Swedish Orphan Biovitrum AB. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Treuheit has collaborated with several professionals in his field, including Sheila R O'Conner and Andrew A Kosky. These collaborations have likely enriched his research and development efforts, leading to advancements in therapeutic formulations.
Conclusion
Michael J Treuheit is a distinguished inventor whose work in therapeutic formulations has made a significant impact in the field. His innovative patents and collaborations reflect his commitment to advancing medical science.